At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Roux en Y Gastric Bypass Surgery (procedure), Gut hormone infusion (other), Placebo infusion (other), Very low calorie diet (other)
- How long the study runs
- Study runs about 180 months (dates as stated)
- About the drug or intervention
- Roux en Y Gastric Bypass Surgery (procedure)
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years to 70 Years
- Who
- All
- Number of participants
- 190
- Started
- 2013-10
- Last checked
- 2021-04
Plain English Summary
What is this study?
- • Testing a new treatment for obesity
- • NA - 190 participants
- • The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively
Who can take part?
- • Ages 18 Years to 70 Years
- • Diagnosed with obesity
Where?
- • London - NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.
More detail
This study is designed to investigate whether chronic elevation of glucagon-like peptide-1 (GLP-1), oxyntomodulin and peptide YY (PYY) in combination is responsible for the majority of the metabolic effects of Roux-en-Y gastric bypass (RYGB) including improved glycaemia, increased energy expenditure, reduced food intake, weight loss, reduced preference for high calorie foods and reduced activation in brain reward areas in response to visual food cues.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 70 Years
- Who can join: All genders
What the study is looking for
- ✓Inclusion criteria
- ✓Aged 18 - 70 years.
- ✓Male or female.
- ✓Eligible for bariatric surgery under the NHS.
- ✓Diagnosed with impaired glucose regulation or type 2 diabetes, according to WHO 2011 criteria.
See the full criteria
Where Is This Study? (1 UK site)
NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital
London, United Kingdom
How to Get in Touch
Tricia Tan, MBChB MRCP
Sponsor contactCONTACT
